Coping with new treatments for cancer: a feasibility study of daily diary measures. (Q53527658)

15 May 2018

title

Coping with new treatments for cancer: a feasibility study of daily diary measures. (English)

1 reference

15 May 2018

1 reference

2

1 reference

15 May 2018

author name string

Sherliker L

series ordinal

1

1 reference

15 May 2018

publication date

1 April 2000

1 reference

15 May 2018

Patient Education and Counseling

published in

1 reference

15 May 2018

volume

40

1 reference

15 May 2018

issue

1

1 reference

15 May 2018

page(s)

11-19

1 reference

15 May 2018

Methodological issues and research strategies in the study of coping with cancer

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0738-3991%2899%2900047-6

7 January 2021

Psychological response to breast cancer: effect on outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0738-3991%2899%2900047-6

7 January 2021

The relationship of psychosocial factors to prognostic indicators in cutaneous malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0738-3991%2899%2900047-6

7 January 2021

Psychosocial adjustment in women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0738-3991%2899%2900047-6

7 January 2021

Are coping strategies related to disease outcome in early breast cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0738-3991%2899%2900047-6

7 January 2021

Coping, psychosocial well-being and anxiety in cancer patients at follow-up visits

1 reference

https://api.crossref.org/works/10.1016%2FS0738-3991%2899%2900047-6

7 January 2021

Coping and the outcome of stoma surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0738-3991%2899%2900047-6

7 January 2021

Maladaptive coping and affective disorders among cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0738-3991%2899%2900047-6

7 January 2021

EORTC New Drug Development Office coordinating and monitoring programme for phase I and II trials with new anticancer agents

1 reference

https://api.crossref.org/works/10.1016%2FS0738-3991%2899%2900047-6

7 January 2021

Critical role of phase I clinical trials in cancer treatment. American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0738-3991%2899%2900047-6

7 January 2021

Responses and toxic deaths in phase I clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0738-3991%2899%2900047-6

7 January 2021

Prognostic factors for survival in patients treated in phase I clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0738-3991%2899%2900047-6

7 January 2021

Patient motivation and informed consent in a phase I study of an anticancer agent

1 reference

https://api.crossref.org/works/10.1016%2FS0738-3991%2899%2900047-6

7 January 2021

Perceptions of cancer patients and their physicians involved in phase I trials

1 reference

https://api.crossref.org/works/10.1016%2FS0738-3991%2899%2900047-6

7 January 2021

Ethical issues in phase I oncology research: a comparison of investigators and institutional review board chairpersons

1 reference

https://api.crossref.org/works/10.1016%2FS0738-3991%2899%2900047-6

7 January 2021

Informed consent for phase I studies: evaluation of quantity and quality of information provided to patients

1 reference

https://api.crossref.org/works/10.1016%2FS0738-3991%2899%2900047-6

7 January 2021

Psychosocial aspects of participation in early anticancer drug trials. Report of a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0738-3991%2899%2900047-6

7 January 2021

MRC quality of life studies using a daily diary card--practical lessons learned from cancer trials

1 reference

https://api.crossref.org/works/10.1016%2FS0738-3991%2899%2900047-6

7 January 2021

Patients' adjustment to cancer: the Mental Adjustment to Cancer (MAC) scale vs clinical ratings.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-3991%2899%2900047-6

7 January 2021

The factor structure and factor stability of the hospital anxiety and depression scale in patients with cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-3991%2899%2900047-6

7 January 2021

Screening for psychiatric morbidity in patients with advanced breast cancer: validation of two self-report questionnaires

1 reference

https://api.crossref.org/works/10.1016%2FS0738-3991%2899%2900047-6

7 January 2021

Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist

1 reference

https://api.crossref.org/works/10.1016%2FS0738-3991%2899%2900047-6

7 January 2021

Assessing quality of life in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0738-3991%2899%2900047-6

7 January 2021

Exercise and the experience and appraisal of daily stressors: a naturalistic study.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-3991%2899%2900047-6

7 January 2021

Assessing coping strategies: a theoretically based approach.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-3991%2899%2900047-6

7 January 2021

How coping mediates the effect of optimism on distress: a study of women with early stage breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-3991%2899%2900047-6

7 January 2021

Ethical and practical problems of early anti-cancer drug trials: a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0738-3991%2899%2900047-6

7 January 2021

Psychiatric morbidity in patients with advanced cancer of the breast: prevalence measured by two self-rating questionnaires

1 reference

https://api.crossref.org/works/10.1016%2FS0738-3991%2899%2900047-6

7 January 2021

Psychological morbidity in newly referred patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0738-3991%2899%2900047-6

7 January 2021

Appropriate chemotherapy for palliating advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0738-3991%2899%2900047-6

7 January 2021

Satisfaction with communication, medical knowledge, and coping style in patients with metastatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0738-3991%2899%2900047-6

7 January 2021

Psychosocial influences on upper respiratory infectious illness in children

1 reference

https://api.crossref.org/works/10.1016%2FS0738-3991%2899%2900047-6

7 January 2021

Coping styles associated with psychological adjustment to advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0738-3991%2899%2900047-6

7 January 2021

The relative efficacy of avoidant and nonavoidant coping strategies: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0738-3991%2899%2900047-6

7 January 2021

10.1016/S0738-3991(99)00047-6

Identifiers

DOI

1 reference

15 May 2018

PubMed ID

10705060

1 reference

15 May 2018